Synthetic biotechnology company, Amyris (NASDAQ:AMRS) Board of Directors will execute on a transformation program to accelerate improvements to the company's cost and capital structure and liquidity. ...
Source LinkSynthetic biotechnology company, Amyris (NASDAQ:AMRS) Board of Directors will execute on a transformation program to accelerate improvements to the company's cost and capital structure and liquidity. ...
Source Link
Comments